These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 9551236
1. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W. Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236 [Abstract] [Full Text] [Related]
2. Cross-resistance and cross-susceptibility between fluoroquinolone agents. Barry AL, Fuchs PC. Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1013-8. PubMed ID: 1666360 [Abstract] [Full Text] [Related]
3. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones. Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE. Chemotherapy; 1998 Dec; 44(2):85-93. PubMed ID: 9551237 [Abstract] [Full Text] [Related]
4. In-vitro activity of fleroxacin compared with three other quinolones. Bremner DA, Dickie AS, Singh KP. J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536 [Abstract] [Full Text] [Related]
5. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin]. Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G. Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519 [Abstract] [Full Text] [Related]
7. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. McCarter YS, Mazens-Sullivan MF, Bartlett RC. Chemotherapy; 1992 Oct; 38(5):308-18. PubMed ID: 1337507 [Abstract] [Full Text] [Related]
8. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers. Beskid G, Prosser BL. Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919 [Abstract] [Full Text] [Related]
9. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin. Barry AL, Fuchs PC. J Antimicrob Chemother; 1991 Nov 22; 28(5):695-9. PubMed ID: 1663929 [Abstract] [Full Text] [Related]
10. Antibacterial activity of fluoroquinolones in combination with zidovudine. Lewin CS, Allen RA, Amyes SG. J Med Microbiol; 1990 Oct 22; 33(2):127-31. PubMed ID: 2121991 [Abstract] [Full Text] [Related]
11. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections. Naber KG, Hollauer K, Kirchbauer D, Witte W. Int J Antimicrob Agents; 2000 Nov 22; 16(3):239-43. PubMed ID: 11091042 [Abstract] [Full Text] [Related]
14. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies. Fernandes PB, Swanson RN. Drugs Exp Clin Res; 1988 Nov 22; 14(6):375-8. PubMed ID: 3145851 [Abstract] [Full Text] [Related]
17. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections]. Tunçkanat F, Yuluğ N. Mikrobiyol Bul; 1988 Nov 22; 22(3):187-92. PubMed ID: 3252111 [Abstract] [Full Text] [Related]
18. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. Gorzynski EA, Gutman SI, Allen W. Antimicrob Agents Chemother; 1989 Apr 22; 33(4):591-2. PubMed ID: 2524998 [Abstract] [Full Text] [Related]
19. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria]. Habiyaremye I, Verbist L, Vandepitte J. Pathol Biol (Paris); 1987 Jun 22; 35(5 Pt 2):800-4. PubMed ID: 3116489 [Abstract] [Full Text] [Related]